LY4057996

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4057996, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes [Phase 1]